Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Gastric Cancer

  Free Subscription


Articles published in Br J Cancer

Retrieve available abstracts of 36 articles:
HTML format
Text format



Single Articles


    March 2017
  1. SONG Y, Wang Y, Tong C, Xi H, et al
    A unified model of the hierarchical and stochastic theories of gastric cancer.
    Br J Cancer. 2017 Mar 16. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


    February 2017
  2. LIANG X, Shi H, Yang L, Qiu C, et al
    Inhibition of polypyrimidine tract-binding protein 3 induces apoptosis and cell cycle arrest, and enhances the cytotoxicity of 5- fluorouracil in gastric cancer cells.
    Br J Cancer. 2017 Feb 21. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


    January 2017
  3. LI P, Chen H, Chen S, Mo X, et al
    Circular RNA 0000096 affects cell growth and migration in gastric cancer.
    Br J Cancer. 2017 Jan 12. doi: 10.1038/bjc.2016.
    PubMed     Text format     Abstract available


    December 2016
  4. KODAMA H, Murata S, Ishida M, Yamamoto H, et al
    Prognostic impact of CD44-positive cancer stem-like cells at the invasive front of gastric cancer.
    Br J Cancer. 2016 Dec 8. doi: 10.1038/bjc.2016.
    PubMed     Text format     Abstract available


    November 2016
  5. OHASHI T, Komatsu S, Ichikawa D, Miyamae M, et al
    Overexpression of PBK/TOPK relates to tumour malignant potential and poor outcome of gastric carcinoma.
    Br J Cancer. 2016 Nov 29. doi: 10.1038/bjc.2016.
    PubMed     Text format     Abstract available


    August 2016
  6. MARTIN-ROMANO P, Sola JJ, Diaz-Gonzalez JA, Chopitea A, et al
    Role of histological regression grade after two neoadjuvant approaches with or without radiotherapy in locally advanced gastric cancer.
    Br J Cancer. 2016 Aug 18. doi: 10.1038/bjc.2016.
    PubMed     Text format     Abstract available


    May 2016
  7. WANG X, Zhao L, Liu H, Zhong D, et al
    A phase II study of a modified FOLFOX6 regimen as neoadjuvant chemotherapy for locally advanced gastric cancer.
    Br J Cancer. 2016 May 12. doi: 10.1038/bjc.2016.
    PubMed     Text format     Abstract available


  8. YOO C, Ryu MH, Na YS, Ryoo BY, et al
    Vorinostat in combination with capecitabine plus cisplatin as a first-line chemotherapy for patients with metastatic or unresectable gastric cancer: phase II study and biomarker analysis.
    Br J Cancer. 2016 May 12. doi: 10.1038/bjc.2016.
    PubMed     Text format     Abstract available


    April 2016
  9. SONG D, Yue L, Li H, Zhang J, et al
    Diagnostic and prognostic role of serum protein peak at 6449 m/z in gastric adenocarcinoma based on mass spectrometry.
    Br J Cancer. 2016;114:929-38.
    PubMed     Text format     Abstract available


    March 2016
  10. HACKER UT, Escalona-Espinosa L, Consalvo N, Goede V, et al
    Evaluation of Angiopoietin-2 as a biomarker in gastric cancer: results from the randomised phase III AVAGAST trial.
    Br J Cancer. 2016 Mar 31. doi: 10.1038/bjc.2016.
    PubMed     Text format     Abstract available


  11. TEBBUTT NC, Price TJ, Ferraro DA, Wong N, et al
    Panitumumab added to docetaxel, cisplatin and fluoropyrimidine in oesophagogastric cancer: ATTAX3 phase II trial.
    Br J Cancer. 2016;114:505-9.
    PubMed     Text format     Abstract available


    January 2016
  12. LI Y, Gong J, Zhang Q, Lu Z, et al
    Dynamic monitoring of circulating tumour cells to evaluate therapeutic efficacy in advanced gastric cancer.
    Br J Cancer. 2016;114:138-45.
    PubMed     Text format     Abstract available


    December 2015
  13. KAWANAKA M, Watari J, Kamiya N, Yamasaki T, et al
    Effects of Helicobacter pylori eradication on the development of metachronous gastric cancer after endoscopic treatment: analysis of molecular alterations by a randomised controlled trial.
    Br J Cancer. 2015 Dec 15. doi: 10.1038/bjc.2015.
    PubMed     Text format     Abstract available


  14. CHAN AW, Mercier P, Schiller D, Bailey R, et al
    H-NMR urinary metabolomic profiling for diagnosis of gastric cancer.
    Br J Cancer. 2015 Dec 8. doi: 10.1038/bjc.2015.
    PubMed     Text format     Abstract available


  15. CAI J, Feng D, Hu L, Chen H, et al
    FAT4 functions as a tumour suppressor in gastric cancer by modulating Wnt/beta-catenin signalling.
    Br J Cancer. 2015 Dec 3. doi: 10.1038/bjc.2015.
    PubMed     Text format     Abstract available


    November 2015
  16. DE SILVA N, Schulz L, Paterson A, Qain W, et al
    Molecular effects of Lapatinib in the treatment of HER2 overexpressing oesophago-gastric adenocarcinoma.
    Br J Cancer. 2015;113:1305-12.
    PubMed     Text format     Abstract available


    October 2015
  17. KO YS, Cho SJ, Park J, Kim Y, et al
    Loss of FOXO1 promotes gastric tumour growth and metastasis through upregulation of human epidermal growth factor receptor 2/neu expression.
    Br J Cancer. 2015 Oct 8. doi: 10.1038/bjc.2015.
    PubMed     Text format     Abstract available


    September 2015
  18. MA SH, Jung W, Weiderpass E, Jang J, et al
    Impact of alcohol drinking on gastric cancer development according to Helicobacter pylori infection status.
    Br J Cancer. 2015 Sep 17. doi: 10.1038/bjc.2015.
    PubMed     Text format     Abstract available


  19. TOKUMOTO MW, Tanaka H, Tauchi Y, Kasashima H, et al
    Identification of tumour-reactive lymphatic endothelial cells capable of inducing progression of gastric cancer.
    Br J Cancer. 2015 Sep 10. doi: 10.1038/bjc.2015.
    PubMed     Text format     Abstract available


    August 2015
  20. FEILCHENFELDT J, Varga Z, Siano M, Grabsch HI, et al
    Brain metastases in gastro-oesophageal adenocarcinoma: insights into the role of the human epidermal growth factor receptor 2 (HER2).
    Br J Cancer. 2015 Aug 27. doi: 10.1038/bjc.2015.
    PubMed     Text format     Abstract available


  21. JI J, Jia S, Jia Y, Ji K, et al
    WISP-2 in human gastric cancer and its potential metastatic suppressor role in gastric cancer cells mediated by JNK and PLC-gamma pathways.
    Br J Cancer. 2015 Aug 20. doi: 10.1038/bjc.2015.
    PubMed     Text format     Abstract available


    July 2015
  22. NATATSUKA R, Takahashi T, Serada S, Fujimoto M, et al
    Gene therapy with SOCS1 for gastric cancer induces G2/M arrest and has an antitumour effect on peritoneal carcinomatosis.
    Br J Cancer. 2015 Jul 16. doi: 10.1038/bjc.2015.
    PubMed     Text format     Abstract available


    June 2015
  23. KASASHIMA H, Yashiro M, Nakamae H, Masuda G, et al
    Bone marrow-derived stromal cells are associated with gastric cancer progression.
    Br J Cancer. 2015 Jun 30. doi: 10.1038/bjc.2015.
    PubMed     Text format     Abstract available


  24. CARDENAS-MONDRAGON MG, Torres J, Flores-Luna L, Camorlinga-Ponce M, et al
    Case-control study of Epstein-Barr virus and Helicobacter pylori serology in Latin American patients with gastric disease.
    Br J Cancer. 2015;112:1866-73.
    PubMed     Text format     Abstract available


    May 2015
  25. CHEN XZ, Wang R, Hu JK
    Hepatitis B virus infection and gastric cancer risk: pitfalls in the potential association.
    Br J Cancer. 2015;112:1844.
    PubMed     Text format    


  26. FORTUNATO L, Rushton L
    Stomach cancer and occupational exposure to asbestos: a meta-analysis of occupational cohort studies.
    Br J Cancer. 2015;112:1805-15.
    PubMed     Text format     Abstract available


    April 2015
  27. KINUGASA H, Nouso K, Tanaka T, Miyahara K, et al
    Droplet digital PCR measurement of HER2 in patients with gastric cancer.
    Br J Cancer. 2015 Apr 21. doi: 10.1038/bjc.2015.
    PubMed     Text format     Abstract available


    February 2015
  28. WEI XL, Qiu MZ, Jin Y, Huang YX, et al
    Hepatitis B virus infection is associated with gastric cancer in China: an endemic area of both diseases.
    Br J Cancer. 2015 Feb 19. doi: 10.1038/bjc.2014.
    PubMed     Text format     Abstract available


  29. PETRICK JL, Steck SE, Bradshaw PT, Trivers KF, et al
    Dietary intake of flavonoids and oesophageal and gastric cancer: incidence and survival in the United States of America (USA).
    Br J Cancer. 2015 Feb 10. doi: 10.1038/bjc.2015.
    PubMed     Text format     Abstract available


    January 2015
  30. ZHU M, Tang R, Doshi S, Oliner KS, et al
    Exposure-response analysis of rilotumumab in gastric cancer: the role of tumour MET expression.
    Br J Cancer. 2015 Jan 13. doi: 10.1038/bjc.2014.
    PubMed     Text format     Abstract available


    December 2014
  31. KOIZUMI W, Yamaguchi K, Hosaka H, Takinishi Y, et al
    Randomised phase II study of S-1/cisplatin plus TSU-68 vs S-1/cisplatin in patients with advanced gastric cancer.
    Br J Cancer. 2014;111:2382.
    PubMed     Text format    


  32. JAWHARI AU, Noda M, Farthing MJ, Pignatelli M, et al
    Abnormal expression and function of the E-cadherin-catenin complex in gastric carcinoma cell lines.
    Br J Cancer. 2014;111:2381.
    PubMed     Text format    


  33. CHOI KS, Jun JK, Suh M, Park B, et al
    Effect of endoscopy screening on stage at gastric cancer diagnosis: results of the National Cancer Screening Programme in Korea.
    Br J Cancer. 2014 Dec 9. doi: 10.1038/bjc.2014.
    PubMed     Text format     Abstract available


  34. HAMAKAWA T, Kukita Y, Kurokawa Y, Miyazaki Y, et al
    Monitoring gastric cancer progression with circulating tumour DNA.
    Br J Cancer. 2014 Dec 9. doi: 10.1038/bjc.2014.
    PubMed     Text format     Abstract available


  35. ZHANG DS, Jin Y, Luo HY, Wang ZQ, et al
    Pemetrexed for previously treated patients with metastatic gastric cancer: a prospective phase II study.
    Br J Cancer. 2014 Dec 4. doi: 10.1038/bjc.2014.
    PubMed     Text format     Abstract available


    November 2014
  36. HAUPTMANN M, Fossa SD, Stovall M, van Leeuwen FE, et al
    Increased stomach cancer risk following radiotherapy for testicular cancer.
    Br J Cancer. 2014 Nov 4. doi: 10.1038/bjc.2014.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gastric Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: